Noninvasive Methods to Monitor Graft Survival in Heart Transplant Patients

StatusCompleted
PhaseNot specified
Started

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Track this trial
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Re-verified, no change to tracked fieldsv10
  2. Enrollment target: 175 to 263
    • Collaborators: 1 to 2
    v9
  3. Publications: 3 to 4v8
  4. Primary and study completion dates changed from estimate of Jun 2010 to Jul 2011
    • Trial status: Active, Not Recruiting to Completed
    • Study sites: 14 to 12
    v7
  5. Trial status: Recruiting to Active, Not Recruiting
    • Site details revised at 14 of 14 sites
    v6
Show 4 earlier versionsHide 4 earlier versions
  1. Study sites: 12 to 14v5
  2. 2 versions Re-verified since Feb 11, 2008, no change to tracked fieldsv3-v4
  3. Trial status: Not Yet Recruiting to Recruiting
    • Study sites: 14 to 12
    • Primary completion date: Jun 2010
    • Eligibility criteria shortened, about 54 words
    v2
  1. Study First Submitted
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Injury of transplant tissue by a transplant recipient's immune system continues to be the leading cause of graft rejection and recipient death. The purpose of this study is to identify a single test or a combination of noninvasive tests currently used for heart transplant monitoring that correlate to long-term graft survival.
Trial Details
NCT Number NCT00466804
Lead Sponsor National Institute of Allergy and Infectious Diseases (NIAID)
Collaborators: National Heart, Lung, and Blood Institute (NHLBI), Clinical Trials in Organ Transplantation
Conditions
(from sponsor)		 Heart Transplant
Enrollment 263 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov